Hydroxyl functionalized multi-walled carbon nanotubes modulate immune responses without increasing 2009 pandemic influenza A/H1N1 virus titers in infected mice

2020 ◽  
Vol 404 ◽  
pp. 115167
Author(s):  
Hao Chen ◽  
Sara T. Humes ◽  
Melanie Rose ◽  
Sarah E. Robinson ◽  
Julia C. Loeb ◽  
...  
2014 ◽  
Vol 14 (1) ◽  
Author(s):  
Jin Lv ◽  
Dan Wang ◽  
Yan-Hong Hua ◽  
Shi-Jia Pei ◽  
Jin Wang ◽  
...  

2010 ◽  
Vol 16 (S2) ◽  
pp. 1122-1123
Author(s):  
CS Goldsmith ◽  
MG Metcalfe ◽  
W-J Shieh ◽  
DM Blau ◽  
DC Rollin ◽  
...  

Extended abstract of a paper presented at Microscopy and Microanalysis 2010 in Portland, Oregon, USA, August 1 – August 5, 2010.


2013 ◽  
Vol 19 (3) ◽  
Author(s):  
Rebekah H. Borse ◽  
Sundar S. Shrestha ◽  
Anthony E. Fiore ◽  
Charisma Y. Atkins ◽  
James A. Singleton ◽  
...  

2010 ◽  
Vol 52 (Supplement 1) ◽  
pp. S94-S101 ◽  
Author(s):  
K. B. Janusz ◽  
J. E. Cortes ◽  
F. Serdarevic ◽  
R. C. Jones ◽  
J. D. Jones ◽  
...  

2010 ◽  
Vol 15 (31) ◽  
Author(s):  
K Waalen ◽  
A Kilander ◽  
S G Dudman ◽  
G H Krogh ◽  
T Aune ◽  
...  

The prevalence of antibodies reactive to the 2009 pandemic influenza A(H1N1) was determined in sera collected before the start of the pandemic, during the early phase, and after the main epidemic wave and nationwide vaccination campaign in Norway. A substantial rise in prevalence of antibodies at protective titres, from 3.2% to 44.9%, was observed between August 2009 and January 2010. The highest prevalence, 65.3%, was seen in the age group of 10-19 year-olds.


2010 ◽  
Vol 15 (45) ◽  
Author(s):  
M Aho ◽  
O Lyytikaïnen ◽  
J E Nyholm ◽  
T Kuitunen ◽  
E Rönkkö ◽  
...  

In September 2009, an outbreak of 2009 pandemic influenza A(H1N1) took place in a Finnish garrison. In November 2009, we performed a serological survey among 984 recruits undergoing their military service at the garrison and related the results to self-reported upper respiratory tract infection (URTI) with or without fever. Of 346 volunteers who donated a blood sample, 169 (49%) had pandemic influenza A(H1N1) virus-specific antibodies. Of those, 84 (50%) reported no recent history of URTI, suggesting that a major part of those infected with pandemic influenza A(H1N1) virus may be asymptomatic.


Sign in / Sign up

Export Citation Format

Share Document